Palantir Taps Former Senator Tester as Its Commercial Bet Spreads to Shoes and Insurance

Palantir is deepening its ties to Washington while pushing its software further into the private sector, two tracks that give investors plenty to weigh as the stock rides a broader market rebound.

The company has brought former Democratic Senator Jon Tester on board as an adviser on its government business, a move first reported by NPR. Tester describes the role as advisory rather than lobbying, a distinction that frames how Palantir is positioning the hire. In the opposite direction, Reuters reported that the White House has nominated Palantir manager Michael LoSapio to head the Cybersecurity and Infrastructure Security Agency — another point of contact between the company and the US government.

For shareholders, the value of Tester's arrival hinges on whether his political experience sharpens Palantir's understanding of what state customers need. A recognizable name is interesting; a contribution to the business is what counts.

A commercial footprint that keeps widening

The other half of the story sits outside government. Palantir announced a partnership with AmeriLife a little over a week ago under which the insurer plans to deploy Foundry and AIP across its health and wealth distribution organizations, starting with Crump Life Insurance Services. The breadth is the part worth watching: the rollout begins with a single unit and is meant to extend well beyond it. If AmeriLife follows through, it would be a convincing demonstration of Palantir expanding inside an existing customer.

Should investors sell immediately? Or is it worth buying Palantir?

A similar test case arrived Thursday, when Changshin announced it would use Foundry and AIP in shoe development and production. Because the agreement targets operational workflows at the core of the partner's business, it offers a more grounded yardstick than general enthusiasm about artificial intelligence. The link between development and production opens the prospect of use across connected work processes — provided the announced deployment becomes a permanently used solution.

The growth bar is already high

Both efforts unfold against a steep baseline. In its third-quarter 2026 report roughly a week ago, Palantir posted revenue of $2.313 billion, up 96% year over year. US commercial business climbed 148%. The company also raised its 2026 revenue guidance to $8.530–8.534 billion, and lifted its outlook for full-year revenue growth to 91%, with US commercial growth projected at 143%.

That pace sets the standard against which both the Tester engagement and the new corporate rollouts will be measured. The strategic moves gain weight for investors only if they help sustain the expansion.

A friendlier tape and a nudge higher

Sentiment got a lift from the wider market. Palantir shares rose 4.3% as US equities recovered broadly amid falling oil prices, with media reports attributing the gain to improved risk appetite and to investors reassessing the quarterly numbers after the selling pressure that followed their release. A day earlier, the stock had added 4.9%.

Palantir at a turning point? This analysis reveals what investors need to know now.

Analysts have been adjusting their views as well. Clark Jeffries of Piper Sandler raised his price target to $235 from $231 on November 3, keeping an Overweight rating on the shares.

The cautiously positive read on Palantir rests on tangible anchors: torrid growth, a government business now bolstered by political experience, and announced deployments at Changshin and AmeriLife. What remains to be proven is operational — whether those rollouts turn into durable business and whether the company delivers on its raised guidance.

Ad

Palantir Stock: New Analysis - 10 November

Fresh Palantir information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.

Read our updated Palantir analysis...